Experienced in Activated PI3K Delta Syndrome (APDS)

Kanchan R. Rao

Great Ormond Street Hospital
London, ENG, GB 
Experienced in Activated PI3K Delta Syndrome (APDS)
Great Ormond Street Hospital
London, ENG, GB 
OverviewLocationsClinical Research

Overview

Kanchan Rao practices in London, United Kingdom. Ms. Rao is rated as an Experienced expert by MediFind in the treatment of Activated PI3K Delta Syndrome (APDS). Her top areas of expertise are Hemophagocytic Lymphohistiocytosis, Non-Langerhans-Cell Histiocytosis, Primary Immunodeficiency (PID), Reticulohistiocytoma, and Bone Marrow Transplant.

Her clinical research consists of co-authoring 94 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Activated PI3K Delta Syndrome (APDS).

Gender
Female

Locations

Great Ormond Street Hospital
London, ENG, United Kingdom
Other Locations
Great Ormond Street Hospital for Children
Strete, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Study to Assess the Safety, Overall Tolerability, and Antiviral Activity of Brincidofovir Versus Standard of Care for Treatment of Adenovirus in High-risk Pediatric Allogeneic Hematopoietic Transplant Recipients
Study to Assess the Safety, Overall Tolerability, and Antiviral Activity of Brincidofovir Versus Standard of Care for Treatment of Adenovirus in High-risk Pediatric Allogeneic Hematopoietic Transplant Recipients
Enrollment Status: Terminated
Publish Date: January 25, 2021
Intervention Type: Other, Drug
Study Phase: Phase 2

94 Total Publications

Treosulfan-fludarabine-based conditioning was associated with favourable event-free survival and very low risk of endothelial cell dysfunction in paediatric patients with non-malignant haematological disorders: Analysis of the UK Paediatric Treosulfan Study.
Treosulfan-fludarabine-based conditioning was associated with favourable event-free survival and very low risk of endothelial cell dysfunction in paediatric patients with non-malignant haematological disorders: Analysis of the UK Paediatric Treosulfan Study.
Journal: British journal of haematology
Published: May 23, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Rao's expertise for a condition
ConditionClose
      View All 7 Advanced Conditions
      View All 24 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile